Use of functional highly purified human platelets for the identification of new proteins of the IPP signaling pathway

Thrombosis Research

Volumn 122, Issue 1, 2008, Pages 59-68

  Birschmann, Ingvild ^a   Mietner, Silke ^a   Dittrich, Marcus ^a   Pfrang, Julia ^a   Dandekar, Thomas ^a   Walter, Ulrich ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

IPP signaling pathway; Platelet; Proteome; Purification; Transcriptome

Indexed keywords

DNA BINDING PROTEIN; INTEGRIN LINKED KINASE; PHOSPHOPROTEIN; PROTEIN ALPHA PARVIN; PROTEIN PINCH; PURINERGIC P2Y12 RECEPTOR;

APHERESIS; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; NEPHELOMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE FUNCTION;

ACTININ; ANTIGENS, CD15; BLOOD PLATELETS; BLOOD PROTEINS; CELL SEPARATION; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; HLA-DQ ANTIGENS; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VON WILLEBRAND FACTOR;

EID: 42649094850     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.08.022     Document Type: Article

References (47)

1. Weyrich A.S., and Zimmerman G.A. Platelets: signaling cells in the immune continuum. Trends Immunol 25 (2004) 489-495
2. Bugert P., Dugrillon A., Gunaydin A., Eichler H., and Kluter H. Messenger RNA profiling of human platelets by microarray hybridization. Thromb Haemost 90 (2003) 738-748
3. Gnatenko D.V., Dunn J.J., McCorkle S.R., Weissmann D., Perrotta P.L., and Bahou W.F. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 101 (2003) 2285-2293
4. Rox J.M., Bugert P., Muller J., Schorr A., Hanfland P., Madlener K., et al. Gene expression analysis in platelets from a single donor: evaluation of a PCR-based amplification technique. Clin Chem 50 (2004) 2271-2278
5. Dittrich M., Birschmann I., Pfrang J., Herterich S., Smolenski A., Walter U., et al. Analysis of SAGE data in the platelet: features of active translation and regulation. Thromb Haemost 95 (2006) 643-651
6. Healy A.M., Pickard M.D., Pradhan A.D., Wang Y., Chen Z., Croce K., et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 113 (2006) 2278-2284
7. Hillmann A.G., Harmon S., Park S.D., O'Brien J., Shields D.C., and Kenny D. Comparative RNA expression analyses from small-scale, single-donor platelet samples. J Thromb Haemost 4 (2006) 349-356
8. McRedmond J.P., Park S.D., Reilly D.F., Coppinger J.A., Maguire P.B., Shields D.C., et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics 3 (2004) 133-144
9. Dittrich M., Birschmann I., Stuhlfelder C., Sickmann A., Herterich S., Nieswandt B., et al. Understanding platelets: lessons from proteomics and promises from network analysis. Thromb Haemost 94 (2005) 916-925
10. Gnatenko D.V., Perrotta P.L., and Bahou W.F. Proteomic approaches to dissect platelet function: one-half of the story. Blood 108 (2006) 3983-3991
11. Marcus K., Immler D., Sternberger J., and Meyer H.E. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis 21 (2000) 2622-2636
12. O'Neill E.E., Brock C.J., von Kriegsheim A.F., Pearce A.C., Dwek R.A., Watson S.P., et al. Towards complete analysis of the platelet proteome. Proteomics 2 (2002) 288-305
13. Garcia A., Prabhakar S., Brock C.J., Pearce A.C., Dwek R.A., Watson S.P., et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4 (2004) 656-668
14. Moebius J., Zahedi R.P., Lewandrowski U.U., Walter U., and Sickmann A. The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteomics 4 (2005) 1754-1761
15. Maguire P.B., Wynne K.J., Harney D.F., O'Donoghue N.M., Stephens G., and Fitzgerald D.J. Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics 2 (2002) 642-648
16. Marcus K., Moebius J., and Meyer H.E. Differential analysis of phosphorylated proteins in resting and thrombin-stimulated human platelets. Anal Bioanal Chem 376 (2003) 973-993
17. Garcia A., Prabhakar S., Hughan S., Anderson T.W., Brock C.J., Pearce A.C., et al. Differential proteome analysis of TRAP-activated platelets: involvement of and phosphorylation of RGS proteins. Blood 103 (2004) 2088-2095
18. Garcia A., Senis Y.A., Antrobus R., Hughes C.E., Dwek R.A., Watson S.P., et al. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 6 (2006) 5332-5343
19. Lewandrowski U., Moebius J., Walter U., and Sickmann A. Elucidation of N-glycosylation sites on human platelet proteins-a glycoproteomic approach. Mol Cell Proteomics 5 (2006) 226-233
20. Zhang Y., Chen K., Tu Y., Velyvis A., Yang Y., Qin J., et al. Assembly of the PINCH-ILK-CH-ILKBP complex precedes and is essential for localization of each component to cell-matrix adhesion sites. J Cell Sci 115 (2002) 4777-4786
21. Geiger J., Honig-Liedl P., Schanzenbacher P., and Walter U. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors. Eur J Pharmacol 351 (1998) 235-246
22. Thomas L. Quantitative immuchemische Plasmaprotein-Bestimmung mittels Nephelometrie und Turbidimetrie. Lab Med 14 (1990) 313-320
23. Geiger J., Teichmann L., Grossmann R., Aktas B., Steigerwald U., Walter U., et al. Monitoring of clopidogrel action: comparison of methods. Clin Chem 51 (2005) 957-965
24. Grunberg B., Kruse H.J., Negrescu E.V., and Siess W. Platelet rap1B phosphorylation is a sensitive marker for the action of cyclic AMP-and cyclic GMP-increasing platelet inhibitors and vasodilators. J Cardiovasc Pharmacol 25 (1995) 545-551
25. Saniabadi A.R., Lowe G.D., Belch J.J., Forbes C.D., Prentice C.R., and Barbenel J.C. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood. Thromb Haemost 50 (1983) 718-721
26. Harlow E., and Lane D. Antibodies-a laboratory manual (1988), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
27. Ford T.C., Graham J., and Rickwood D. A new, rapid, one-step method for the isolation of platelets from human blood. Clin Chim Acta 192 (1990) 115-119
28. van der Meer P., Pietersz R., and Reesink H. Leucoreduced platelet concentrates in additive solution: an evaluation of filters and storage containers. Vox Sang 81 (2001) 102-107
29. Dzik S. Principles of counting low numbers of leukocytes in leukoreduced blood components. Transfus Med Rev 11 (1997) 44-55
30. Schwarz U.R., Geiger J., Walter U., and Eigenthaler M. Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets-definition and detection of ticlopidine/clopidogrel effects. Thromb Haemost 82 (1999) 1145-1152
31. Aleil B., Ravanat C., Cazenave J.P., Rochoux G., Heitz A., and Gachet C. Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases. J Thromb Haemost 3 (2005) 85-92
32. Tu Y., Li F., Goicoechea S., and Wu C. The LIM-only protein PINCH directly interacts with integrin-linked kinase and is recruited to integrin-rich sites in spreading cells. Mol Cell Biol 19 (1999) 2425-2434
33. Watson S.P., Bahou W.F., Fitzgerald D., Ouwehand W., Rao A.K., and Leavitt A.D. Mapping the platelet proteome: a report of the ISTH Platelet Physiology Subcommittee. J Thromb Haemost 3 (2005) 2098-2101
34. Fink L., Holschermann H., Kwapiszewska G., Muyal J.P., Lengemann B., Bohle R.M., et al. Characterization of platelet-specific mRNA by real-time PCR after laser-assisted microdissection. Thromb Haemost 90 (2003) 749-756
35. Bagamery K., Kvell K., Barnet M., Landau R., and Graham J. Are platelets activated after a rapid, one-step density gradient centrifugation? Evidence from flow cytometric analysis. Clin Lab Haematol 27 (2005) 75-77
36. Garcia B.A., Smalley D.M., Cho H., Shabanowitz J., Ley K., and Hunt D.F. The platelet microparticle proteome. J Proteome Res 4 (2005) 1516-1521
37. Shiba M., Tadokoro K., Sawanobori M., Nakajima K., Suzuki K., and Juji T. Activation of the contact system by filtration of platelet concentrates with a negatively charged white cell-removal filter and measurement of venous blood bradykinin level in patients who received filtered platelets. Transfusion 37 (1997) 457-462
38. Poole A.W., Heath M.F., and Evans R.J. ADP induces desensitisation of equine platelet aggregation responses: studies using ADP beta S, a stable analogue of ADP. Res Vet Sci 54 (1993) 235-243
39. Holme S., Sixma J.J., Wester J., and Holmsen H. ADP-induced refractory state of platelets in vitro. II. Functional and ultra studies on gel filtered platelets. Scand J Haematol 18 (1977) 267-278
40. Holme S., Holmsen H., and Sixma J.J. Proceedings: ADP-induced refractory state of platelets in vitro. Thromb Diath Haemorrh 34 (1975) 316
41. Hardy A.R., Conley P.B., Luo J., Benovic J.L., Poole A.W., and Mundell S.J. P2Y1 and P2Y12 receptors for ADP desensitize by distinct kinase-dependent mechanisms. Blood 105 (2005) 3552-3560
42. Baurand A., Eckly A., Bari N., Leon C., Hechler B., Cazenave J.P., et al. Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors. Thromb Haemost 84 (2000) 484-491
43. Enjyoji K., Sevigny J., Lin Y., Frenette P.S., Christie P.D., Esch II J.S., et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 5 (1999) 1010-1017
44. Law D.A., Nannizzi-Alaimo L., and Phillips D.R. Outside-in integrin signal transduction. Alpha IIb beta 3-(GP IIb IIIa) tyrosine phosphorylation induced by platelet aggregation. J Biol Chem 271 (1996) 10811-10815
45. Payrastre B., Missy K., Trumel C., Bodin S., Plantavid M., and Chap H. The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem Pharmacol 60 (2000) 1069-1074
46. Pasquet J.M., Noury M., and Nurden A.T. Evidence that the platelet integrin alphaIIb beta3 is regulated by the integrin-linked kinase, ILK, in a PI3-kinase dependent pathway. Thromb Haemost 88 (2002) 115-122
47. Martens L., Van Damme P., Van Damme J., Staes A., Timmerman E., Ghesquiere B., et al. The human platelet proteome mapped by peptide-centric proteomics: a functional protein profile. Proteomics 5 (2005) 3193-3204